Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Alopecia Areata (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology USA
    Advancing Health Literacy in The Republic of Ireland
    Release Date:
    Review Process: Expert Review Panel
    Education Support for the Professions Ireland
    Education to Improve Antimicrobial Resistance (AMR) Management
    Release Date:
    Partner: Japanese Society of Chemotherapy
    Review Process: Expert Review Panel
    Education Hospital Japan
    Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Promote the Streamline and Optimization of Healthcare System to Improve Regional Disparities
    Release Date:
    Partner: Japan Association for Development of Community Medicine
    Review Process: Expert Review Panel
    Quality Improvement Support for the Professions Japan
    Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Establishing Regional Medical Care Coordination System for Detailed examination of the Causes of Heart Failure
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Japan
    Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Ulcerative Colitis (UC) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, United Kingdom
    Evidence-informed treatment decisions in chronic inflammatory disorders
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Australia